platinum has been researched along with jm 221 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abel, G; Harrap, KR; Kelland, LR; McKeage, MJ | 1 |
| Chwalinski, T; Harrap, KR; Kelland, LR; O'Neill, CF; Ormerod, MG; Orr, RM; Titley, JC | 1 |
2 other study(ies) available for platinum and jm 221
| Article | Year |
|---|---|
Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.
Topics: Antineoplastic Agents; Cisplatin; DNA Probes; DNA, Neoplasm; Drug Resistance; Female; Humans; Organoplatinum Compounds; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured | 1994 |
The cytotoxic action of four ammine/amine platinum(IV) dicarboxylates: a flow cytometric study.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Survival; DNA, Neoplasm; Flow Cytometry; Leukemia L1210; Mice; Organoplatinum Compounds; Platinum | 1996 |